WNS-HealthHelp's advanced AI-driven clinical engine, business transformation capabilities and fully delegated specialty programs, in combination with Availity's extensive healthcare network ...

Californians who purchased certain generic drugs between May 2009 and December 2019 may be eligible to file a claim. The settlement agreement with Apotex resolves claims it engaged in efforts to ...

WNS-HealthHelp, a trusted healthcare technology platform for health plans, and a part of WNS, a digital-led business transformation and services company, today announced its strategic collaboration ...

This little pill — taken by adults and children alike — might just be a prescription for heart disease. Speaking to The Post, the veteran heart doctor tackled a drug that is commonly ...

A new drug has shown promise in combating Parkinson’s disease while minimizing unwanted side effects. The once-daily pill, tavapadon, was found to relieve symptoms — including stiffness ...

A new executive order signed Tuesday by President Trump directs Congress to change a key provision of the law allowing Medicare drug price negotiations, a move that would fix one of the drug ...

with implications for formulary management and benefit design. As managed care pharmacy navigates rapid transformations in policies, high-cost drug strategies, and innovative therapies ...

A tranquilizer commonly referred to as a "zombie drug" is being manufactured and smuggled across the U.S. southern border, according to a doctor who has spent years studying it. The drug xylazine ...

Experts discuss how guideline recommendations influence formulary decisions regarding preventive measures like lipoprotein(a) ...

Milwaukee Bucks guard Damian Lillard is off blood-thinning medication and has been cleared for full basketball activity, a major step forward in his return from the deep vein thrombosis that has ...

U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or suspend treatment for patients. U.S. regulators are trying to shut down ...